2019-04-18 Comments Off on MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS LA JOLLA, Calif., April 15, 2019 (GLOBE NEWSWIRE) — MediciNova,